Unichem Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

719.25

-26.20 (-3.51%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

719.25

-26.20 (-3.51%)
16:02 Dec 20

Quality

57/100
High Financial Strength

Valuation

20/100
Expensive Valuation

Technical

52/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	1235.14	1269.83	1343.02	1704.89	1774.67
Operating Expenses +	1144.02	1197.03	1388.58	1604.65	1610.16
Raw Material	467.53	457.36	533.73	743.71	825.84
Increase Decrease in Cost	-88.14	-41.53	17.2	-79.09	-157.42
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	306.97	330.49	356.41	393.06	394.83
Miscellaneous Expenses	458.74	453.41	484.3	548.79	546.91
Operating Profit	91.12	72.8	-45.56	100.24	164.51
Other Income	50.19	47.51	38.52	31.6	30.08
Depreciation	84.36	91.17	113.44	113.24	111.89
Interest	5.12	6.11	17.31	22.66	18.99
Profit before tax and exceptio..	51.82	23.03	-137.8	-4.06	63.71
Exceptional Items	0	0	0	-57.61	-57.61
PBT	51.82	23.03	-137.8	-61.67	121.32
Provision for Taxation	17.15	-11.09	25.86	8.81	11.66
Net Profit	34.67	34.12	-163.66	-70.47	-5.57
NET Profit after MI	34.32	33.06	-202.23	-70.47	-5.57
EPS	4.88	4.7	-28.72	-10.01	-0.79
Operating Profit Margin (%)	7.38	5.73	-3.39	5.88	9.27
Net Profit Margin (%)	2.78	2.6	-15.06	-4.13	-0.31

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	70.20	70.20	70.20	70.20	70.20
FII	0.90	0.90	0.90	0.80	0.80
MF	10.20	10.10	9.80	9.00	8.60
Public	17.20	17.30	17.60	18.20	18.60
Others	0.00	0.00	0.00	0.00	0.10
Others	1.50	1.50	1.50	1.80	1.70